Monte Rosa Therapeutics Provides Corporate Update and Key
Phase 1/2 clinical trial of MRT-2359 in MYC-driven solid tumors on track; recommended Phase 2 dose (RP2D) expected in Q2 ...
Read morePhase 1/2 clinical trial of MRT-2359 in MYC-driven solid tumors on track; recommended Phase 2 dose (RP2D) expected in Q2 ...
Read morePC14586 clinical program to be led by Deepika Jalota, Pharm.D. (Chief Development Officer) and Marc Fellous, M.D. (Senior Vice President, ...
Read moreAs we step into the new year, it's crucial to set ourselves up for financial well-being. Financial planning isn't ...
Read moreGrowing demand for more sustainable IT has seen the number of products with TCO Certified increase 26 percent during the ...
Read moreInvesting in a balanced advantage fund can offer several benefits for investors. These funds are designed to provide a ...
Read moreLet’s suppose you wake up one morning feeling a little under the weather.You decide to see a doctor and ...
Read moreUnlock the Key to Knowledge with NRI's Guide on Managing Real Estate in India, Penned by Mr. Dhananjai Agarwal ...
Read moreNOIDA, India, Dec. 4, 2023 /PRNewswire/ -- Amity Innovation Incubator (AII), a prominent hub nurturing innovation and entrepreneurship, proudly unveils ...
Read moreBANGALORE, India, Dec. 4, 2023 /PRNewswire/ -- OKX, a leading Web3 technology company, today announced its sponsorship of key events at ...
Read moreFRANKLIN, Tenn.--(BUSINESS WIRE)--Educational Media Foundation (EMF), the parent organization of leading Christian radio networks K-LOVE and Air1, has appointed three ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.